Diabetes is the most common disease in our world. In our country over 50.000 of people are
diagnosed with diabetes every year. Diabetes is a metabolic disorder generated by the pancreas
inability to produce insulin in order to complete glucose metabolic process. Therefore, the life of
the patients is sustained by the insulin administration. Existing methods on the market for insulin
administration are not too various and there are a lots of disadvantages. Insulin glargine is a long- action, man-made version of human insulin. It replaces the insulin that is not produced by the body
and helps the metabolic process of glucose. To increase insulin stability and releasing time, zinc
oxide (ZnO) can be used for insulin encapsulation. Collagen is a natural protein that can be used as
a support for controlled releases system because of its high biocompatibility. The aim of this study
was to develop and characterize a controlled released subdermal support, for diabetics patients,
made of a composite material based on collagen, zinc oxide and insulin. Obtained matrices were
characterized by FT-IR spectroscopy, optical and scanning electronic microscopy, water up-take,
degradation in collagenase solution. The results showed that the combination between collagen,
ZnO and insulin could be suitable active supports for subdermal support with controlled delivery
of insulin for diabetics.
Real Time Impact Factor:
Pending
Author Name: Nicoleta Manolache, Madalina Georgiana Albu Kaya, Izabela-Cristina Stancu, ?tefania Marin, Ciprian Chelaru, Diana Dr?gu?in, Vlad Constantin, Georgeta Paunica Panea
URL: View PDF
Keywords: diabetes, collagen, insulin, zinc oxide
ISSN: 2068-0783
EISSN:
EOI/DOI: 10.24264/icams-2016.II.13
Add Citation
Views: 1